Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 7
142
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Toll-Like Receptor 4 Gene Polymorphisms and Susceptibility to Schizophrenia: A Case-Control Study

ORCID Icon, , &

References

  • Abdelsalam M, Abd Elmagid DS, Magdy H, El-Sabbagh AM, Mostafa M. 2020. The association between toll-like receptor 4 (TLR4) genotyping and the risk of epilepsy in children. Egypt J Med Hum Genet. 21(1):61.
  • Abdelsalam M, Allam SH, Zohdy M, Magdy H, Mostafa M. 2021. TLR4 gene polymorphisms in Egyptian vitiligo patients: insights into emerging association with clinical activity, family history, and response to therapy. J Genet Eng Biotechnol. 19(1):132.
  • Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R, et al.$3$2 2004. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol. 173(7):4286–96.
  • Akira S, Takeda K, Kaisho T. 2001. Toll-Like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2(8):675–80.
  • Association AP. 2013. Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, D.C.: American Psychiatric Pub.
  • Balaji R, Subbanna M, Shivakumar V, Abdul F, Venkatasubramanian G, Debnath M. 2020. Pattern of expression of Toll like receptor (TLR)-3 and -4 genes in drug-naïve and antipsychotic treated patients diagnosed with schizophrenia. Psychiatry Res. 285:112727.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21(2):263–65.
  • Bassi GS, Kanashiro A, Santin FM, de Souza GE, Nobre MJ, Coimbra NC. 2012. Lipopolysaccharide-Induced sickness behaviour evaluated in different models of anxiety and innate fear in rats. Basic Clin Pharmacol Toxicol. 110(4):359–69.
  • Bińkowski J, Miks S. 2018. Gene-Calc [Computer software], Sept. [ accessed Jun 22]. http://www.gene-calc.pl.
  • Bradbury TN, Miller GA. 1985. Season of birth in schizophrenia: a review of evidence, methodology, and etiology. Psychol Bull. 98(3):569–94.
  • Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 61(11):1013–21.
  • Castaño-Rodríguez N, Kaakoush NO, Pardo AL, Goh KL, Fock KM, Mitchell HM. 2014. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol. 75(8):808–15.
  • Chaiwiang N, Poyomtip T. 2019. The association of toll-like receptor 4 gene polymorphisms with primary open angle glaucoma susceptibility: a meta-analysis. Biosci Rep. 39(4).
  • Chang SH, Chiang SY, Chiu CC, Tsai CC, Tsai HH, Huang CY, et al.$3$2 2011. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia. Psychiatry Res. 187(3):341–46.
  • Chen Y-C, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. 2005. Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer. Cancer Res. 65(24):11771–78.
  • De Miranda J, Yaddanapudi K, Hornig M, Villar G, Serge R, Lipkin WI. 2010. Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. Mbio. 1(4). doi:10.1128/mBio.00176-10
  • Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I, Lawson BR. 2012. Toll-Like receptors and their role in renal pathologies. Inflamm Allergy Drug Targets. 11(6):464–77.
  • First MB, Spitzer RL, Gibbon M, and Williams JB. 2002. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition, New York: Biometrics Research, New York State Psychiatric Institute.
  • Garate I, Garcia-Bueno B, Madrigal JL, Bravo L, Berrocoso E, Caso JR, et al.$3$2 2011. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation. 8:151.
  • García-Bueno B, Gassó P, MacDowell KS, Callado LF, Mas S, Bernardo M, Lafuente A, Meana JJ, Leza JC. 2016. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia. J Psychiatry Neurosci. 41(3):E46–E55.
  • Gu L, Huang J, Liang B, Chen Q, Xie J, Yang J, et al.$3$2 2018. TLR4 polymorphisms affect stroke risk and inflammatory response in Chinese ischemic stroke patients. Neurol Sci. 39(1):127–33.
  • Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. 2011. Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci. 56(4):1131–37.
  • Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 162(7):3749–52.
  • Huang L, Yuan K, Liu J, Ren X, Dong X, Tian W, et al.$3$2 2014. Polymorphisms of the TLR4 gene and risk of gastric cancer. Gene. 537(1):46–50.
  • Hung YY, Kang HY, Huang KW, Huang TL. 2014. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res. 220(1–2):283–86.
  • Jenkins T (2013). Perinatal complications and schizophrenia: involvement of the immune system [Review]. Frontiers in neuroscience 7:110. doi:10.3389/fnins.2013.00110.
  • Jiao Y, Zhao J, Hu B, La X, Gong X, Huang Y, et al.$3$2 2016. Toll-Like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang. Exp Ther Med. 12(5):3268–74.
  • Jin C, Flavell RA. 2013. Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol. 132(2):287–94.
  • Joshi JC, Ray A, Gulati K. 2015. Effects of morphine on stress induced anxiety in rats: role of nitric oxide and Hsp70. Physiol Behav. 139:393–96.
  • Kaisho T, Akira S. 2001. Toll-Like receptors and their signaling mechanism in innate immunity. Acta Odontol Scand. 59(3):124–30.
  • Karageorgiou V, Milas GP, Michopoulos I. 2019. Neutrophil-To-Lymphocyte ratio in schizophrenia: a systematic review and meta-analysis. Schizophr Res. 206:4–12.
  • Kastelijn EA, van Moorsel CH, Rijkers GT, Ruven HJ, Karthaus V, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC, et al. 2010. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant. 29(6):665–71.
  • Kaul D, Habbel P, Derkow K, Krüger C, Franzoni E, Wulczyn FG, Bereswill S, Nitsch R, Schott E, Veh R, et al. 2012. Expression of Toll-like receptors in the developing brain. PLoS One. 7(5):e37767.
  • Kawai T, Akira S. 2011. Toll-Like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 34(5):637–50.
  • Kay SR, Opler LA, Lindenmayer J-P. 1988. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry res. 23(1):99–110.
  • Kéri S, Szabó C, Kelemen O. 2017. Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia. Brain Behav Immun. 62:256–64.
  • Larsen PH, Holm TH, Owens T. 2007. Toll-Like receptors in brain development and homeostasis. Sci STKE. 2007(402):pe47.
  • Li T, Jing J, Sun L, Jiang B, Xin S, Yang J, et al.$3$2 2019. TLR4 and MMP2 polymorphisms and their associations with cardiovascular risk factors in susceptibility to aortic aneurysmal diseases. Biosci Rep. 39(1):BSR20181591.
  • Ling Y, Xiong F. 2019. Associations of TLR4 gene polymorphisms with the risk of age-related macular degeneration in a Chinese Han population. Medicine. 98(19):e15583.
  • M-K W, Huang T-L, Huang K-W, Huang Y-L, Hung Y-Y. 2015. Association between toll-like receptor 4 expression and symptoms of major depressive disorder. Neuropsychiatr Dis Treat. 11:1853–57.
  • Maes M, Kubera M, Leunis J-C, Berk M 2012. Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut. 55–62. doi:10.1016/j.jad.2012.02.023.
  • Malki K, Pain O, Tosto MG, Du Rietz E, Carboni L, Schalkwyk LC. 2015. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry. 5:e519.
  • McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG. 2011. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry. 1:e36.
  • Miuller N, Schwarz MJ. 2007. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm. Suppl(72):269–80.
  • Moaaz M, Youssry S, Moaz A, Abdelrahman M. 2020. Study of Toll‑Like receptor 4 gene polymorphisms in colorectal cancer: correlation with clinicopathological features. Immunol Invest. 49(5):571–84.
  • Molteni M, Gemma S, Rossetti C. 2016. The role of Toll-Like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm. 2016:6978936.
  • Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, Andersen PK, Melbye M. 1999. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med. 340(8):603–08.
  • Muller N, Myint AM, Schwarz MJ. 2011. Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. Curr Pharm Des. 17(2):130–36.
  • Müller N, Schwarz MJ. 2010. Immune System and Schizophrenia. Curr Immunol Rev. 6(3):213–20.
  • Müller N, Wagner JK, Krause D, Weidinger E, Wildenauer A, Obermeier M, et al., Impaired monocyte activation in schizophrenia. Psychiatry Res. 2012;198(3):341–46. doi:10.1016/j.psychres.2011.12.049
  • Neamatallah M, El-Bendary M, Elalfy H, Besheer T, El-Maksoud MA, Elhammady D, Abed S, Elegezy M, Kandeel L, Eldeib D, et al. 2020. Impact of Toll-like receptors 2(TLR2) and TLR 4 gene variations on HCV susceptibility, response to treatment and development of hepatocellular carcinoma in cirrhotic HCV patients. Immunol Invest. 49(4):462–76.
  • Okun E, Griffioen K, Barak B, Roberts NJ, Castro K, Pita MA, Cheng A, Mughal MR, Wan R, Ashery U, et al. 2010. Toll-Like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci U S A. 107(35):15625–30.
  • Okun E, Barak B, Saada-Madar R, Rothman SM, Griffioen KJ, Roberts N, Castro K, Mughal MR, Pita MA, Stranahan AM, et al. 2012. Evidence for a developmental role for TLR4 in learning and memory. PLoS One. 7(10):e47522.
  • Oliveira J, Busson M, Etain B, Jamain S, Hamdani N, Boukouaci W, Amokrane K, Bennabi M, Le Guen E, Dargel AA, et al. 2014. Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J Affect Disord. 152–154:395–402.
  • Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 173(6):3916–24.
  • Pandey GN, Rizavi HS, Ren X, Bhaumik R, Dwivedi Y. 2014. Toll-Like receptors in the depressed and suicide brain. J Psychiatr Res. 53:62–68.
  • Pascual M, Balino P, Aragon CM, Guerri C. 2015. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2. Neuropharmacology. 89:352–59.
  • Peakall R, Smouse PE. 2012. GenAlex 6.5: genetic analysis in Excel. Population genetic software for teaching and research–an update. Bioinformatics. 28(19):2537–39.
  • Rao JS, Kim HW, Harry GJ, Rapoport SI, and Reese EA. 2013. RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr Res. 147(1):24–31.
  • Saha S, Chant D, Welham J, McGrath J. 2005. A systematic review of the prevalence of schizophrenia. PLoS Med. 2(5):e141.
  • Sato K, Yoshimura A, Kaneko T, Ukai T, Ozaki Y, Nakamura H, Li X, Matsumura H, Hara Y, Ogata Y. 2012. A single nucleotide polymorphism in 3’-untranslated region contributes to the regulation of Toll-like receptor 4 translation. J Biol Chem. 287(30):25163–72.
  • Saunders JC, Muchmore E. 1964. Phenothiazine effect on human antibody synthesis. Br J Psychiatry. 110:84–89.
  • Shen Y, Liu Y, Liu S, Zhang AJP, Research O. 2013. Toll-Like receptor 4 gene polymorphisms and susceptibility to bladder cancer. Pathol Oncol Res. 19(2):275–80.
  • Singh K, Singh VK, Agrawal NK, Gupta SK, Singh K. 2013. Association of Toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. Biomed Res Int. 2013:1–9.
  • Solé X, Guinó E, Valls J, Iniesta R, Moreno V. 2006. Snpstats: a web tool for the analysis of association studies. Bioinformatics. 22(15):1928–29.
  • Song Y, Liu H, Long L, Zhang N, Liu YJM. 2015. TLR4 rs1927911, but Not TLR2 rs5743708, is associated with atherosclerotic cerebral infarction in the Southern Han population: a case–control study. Medicine. 94(2). doi:10.1097/MD.0000000000000381
  • Song J, Kim DY, Kim CS, Kim HJ, Lee DH, Lee HM, et al.$3$2 2009. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet Cytogenet. 190(2):88–92.
  • Taha HS, Sheir RE, Shafy SS, Mohamed LM. 2014. Genotypic analysis of Asp299Gly and Thr399Ile polymorphisms of TLR4 in Egyptian patients with rheumatoid arthritis and systemic lupus. 26:15–20.
  • Takeda K, Kaisho T, Akira S. 2003. Toll-Like receptors. Annu Rev Immunol. 21:335–76.
  • Taylor BD, Darville T, Ferrell RE, Kammerer CM, Ness RB, Haggerty CL. 2012. Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease. J Infect Dis. 205(4):603–09.
  • Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. 2006. Control of translation and mRNA degradation by miRnas and siRnas. Genes Dev. 20(5):515–24.
  • Venkatasubramanian G, Debnath M. 2013. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 44:301–11.
  • Wallet SM, Puri V, Gibson FC. 2018. Linkage of infection to adverse systemic complications: periodontal disease, Toll-like receptors, and other pattern recognition systems. Vaccines. 6(2):21.
  • Wang H, Wei Y, Zeng Y, Qin Y, Xiong B, Qin G, et al.$3$2 2014. The association of polymorphisms of TLR4 and CD14genes with susceptibility to sepsis in a Chinese population. BMC Med Genet. 15(1):123.
  • Whelan R, St Clair D, Mustard CJ, Hallford P, Wei J. 2018. Study of novel autoantibodies in Schizophrenia. Schizophr Bull. 44(6):1341–49.
  • Wong J-L, Aym A, Ritchie W, Rasko JEJ. 2016. Intron retention in mRNA: No longer nonsense. 38(1):41–49.
  • Wright P, Takei N, Rifkin L, Murray RM. 1995. Maternal influenza, obstetric complications, and schizophrenia. Am J Psychiatry. 152(12):1714–20.
  • Xu Y, Jiang Z, Huang J, Meng Q, Coh P, Tao L The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes. 2015;99(9):1301–05. doi:10.1136/bjophthalmol-2015-306677
  • Young AM, Campbell E, Lynch S, Suckling J, Powis SJ. 2011. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front Psychiatry. 2:27.
  • Zamzam YA, El-Sorogy H, Attia G, Al-Mahalawy M. 2019. Association of Toll-like Receptor 4 +3725G/C Polymorphism in Egyptian Breast Cancer Patients. Int J Curr Microbiol App Sci. 8:2429–37.
  • Zhao J, Han X, Xue L, Zhu K, Liu H, Xie A. 2015. Association of TLR4 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neurol Sci. 36(9):1659–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.